Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Redo Percutaneous Mitral Valvuloplasty (Redo Pmv) in Patients With Recurrent Mitral Valve Stenosis: Immediate and Early Outcomes



Ghasemi M1 ; Mehrpooya M2 ; Ghasemi F3 ; Movahed MR4 ; Sattartabar B5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center of Endovascular Intervention, Department of Interventional Cardiology, Imam Khomeini Hospital complex, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Interventional Cardiology, Imam Khomeini Hospital complex, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. University of Toronto, Mount Sinai Hospital, 700 University Avenue, Toronto, M5G, ON, Canada
  4. 4. University of Arizona, Tucson, AZ, United States
  5. 5. Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Iranian Medical Council Published:2019

Abstract

Background: Symptomatic recurrent mitral valve stenosis develops in some patients after Percutaneous Mitral Valvuloplasty (PMV). This study assessed the immediate and early outcomes of redo PMV in patients with recurrent mitral valve stenosis after prior PMV. Methods: Fifty-four patients (40 women and 14 men, mean age of 38±8.2 years) underwent a redo (second) PMV for symptomatic restenosis of mitral valve [with Mitral Valve Area (MVA) < 1.5 cm2]. Redo PMV was performed at 5.8±1.2 years after the initial PMV. Results: In this study, 48 hours after the procedure, there was a substantial increase in MVA by 2-dimensional Echocardiography (GE, Vivid 7) from 1.0±0.2 to 2.2±0.4 cm2 (p<0.001) and a decrease in mean left atrial pressure from 27 ± 5 to 15 ± 4 mmHg (p<0.001) and in mean transmitral valve gradient from 15±4 to 2±1 mmHg (p <0 .001). Mean pulmonary artery pressure did not change significantly with redo procedure. Good immediate result was achieved in 53 patients (98.15%). Conclusion: Redo PMV can be performed successfully in patients with recurrent mitral valve stenosis following previous percutaneous valvuloplasty. © Journal of Iranian Medical Council 2019.